SCHEMBL1590583

SCHEMBL1590583

C[C@@H](C(N)=O)n1ccc2c(NC(=O)Cc3ccc(Cl)c(C(F)(F)F)c3)cccc2c1=O

nearest known ligand 0.80

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 11/20 0.80
TRPV1 Q8NER1 2/20 0.43
AURKA O14965 2/20 0.43
RPS6KB1 P23443 2/20 0.43
AURKB Q96GD4 1/20 0.43
KCNJ5 P48544 1/20 0.41
KCNJ3 P48549 1/20 0.41
CSF1R P07333 1/20 0.41
RET P07949 1/20 0.41
PDGFRB P09619 1/20 0.41
KIT P10721 1/20 0.41
PDGFRA P16234 1/20 0.41
DDR1 Q08345 1/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CLK1 P49759 1/20 0.41
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1589987 1.00 P2RX7 (0.80) P2RX7TRPV1AURKARPS6KB1AURKB
SCHEMBL1589983 1.00 P2RX7 (0.80) P2RX7TRPV1AURKARPS6KB1AURKB
SCHEMBL1591218 0.90 P2RX7 (0.65) P2RX7TRPV1RPS6KB1CSF1RPDGFRB
SCHEMBL1590130 0.90 P2RX7 (0.65) P2RX7TRPV1RPS6KB1CSF1RPDGFRB
SCHEMBL1590135 0.90 P2RX7 (0.65) P2RX7TRPV1RPS6KB1CSF1RPDGFRB
SCHEMBL1591180 0.89 P2RX7 (0.63) P2RX7TRPV1MAPTKDM4ECLK1
SCHEMBL1590253 0.89 P2RX7 (0.63) P2RX7TRPV1MAPTKDM4ECLK1
SCHEMBL1590258 0.89 P2RX7 (0.63) P2RX7TRPV1MAPTKDM4ECLK1
SCHEMBL1590002 0.89 P2RX7 (0.79) P2RX7TRPV1AURKARPS6KB1AURKB
SCHEMBL1590001 0.89 P2RX7 (0.79) P2RX7TRPV1AURKARPS6KB1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. 2011-04-21 US claimed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US claimed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US claimed
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. 2011-04-21 US disclosed
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. 2011-04-21 US disclosed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US disclosed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US disclosed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US disclosed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof P2RX7, P2RX3, P2RX2 P2RX7 1/4885TRPV1 19/4885AURKA 3947/4885
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof P2RX7, P2RX3, P2RX2 P2RX7 1/4885TRPV1 19/4885AURKA 3947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.